pillbase.ru

Vijoice

Active substance: alpelisib

alpelisib

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 13
  • PIQRAY
    KIT · alpelisib
    0078-0715
    Novartis Pharmaceuticals Corporation
  • PIQRAY
    TABLET · ALPELISIB 150 mg/1
    0078-0708
    Novartis Pharmaceuticals Corporation
  • PIQRAY
    TABLET · ALPELISIB 200 mg/1
    0078-0701
    Novartis Pharmaceuticals Corporation
  • VIJOICE
    GRANULE · ALPELISIB 50 mg/1
    0078-1175
    Novartis Pharmaceuticals Corporation
  • VIJOICE
    TABLET · ALPELISIB 50 mg/1
    0078-1021
    Novartis Pharmaceuticals Corporation
All products in this country (13)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-45ca-705a-b45d-4d6f1b01dc65,01a1208c-4872-7ee8-8493-f7ff4114b145,01a1208d-f7d5-7233-a954-12b143520885,01a1208e-03fa-7d22-a83e-5468b25312d4,01a1208f-7d3d-70e4-84ef-57227ed57c22;count=13 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005468
Registration status
Active
ATC code
L01EM03
Sources
  • product · EMA · EMEA/H/C/005468 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005468 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005468 · Verified 2026-10-09